Literature DB >> 16236519

Mammalian cyclin-dependent kinases.

Marcos Malumbres1, Mariano Barbacid.   

Abstract

Cyclin-dependent kinases (Cdks) are the catalytic subunits of a family of mammalian heterodimeric serine/threonine kinases that have been implicated in the control of cell-cycle progression, transcription and neuronal function. Recent genetic evidence obtained with gene-targeted mice has shown that Cdk4 and Cdk6 are not needed for entry into the cell cycle after mitogenic stimuli and organogenesis; however, they are essential for the proliferation of some endocrine and hematopoietic cells. Cdk2 is also dispensable for the mitotic cell cycle. Indeed, mice without Cdk2 are normal except for their complete sterility: unexpectedly, Cdk2 is crucial for the first meiotic division of male and female germ cells. These findings have important implications both for our current understanding of the role of Cdks in regulating the mammalian cell cycle and for their potential use as therapeutic targets in cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16236519     DOI: 10.1016/j.tibs.2005.09.005

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  428 in total

1.  Regulation of a Myb transcription factor by cyclin-dependent kinase 2 in Giardia lamblia.

Authors:  Chao-Cheng Cho; Li-Hsin Su; Yu-Chang Huang; Yu-Jiao Pan; Chin-Hung Sun
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

2.  5-Aminoimidazole-4-carboxyamide ribonucleoside induces G(1)/S arrest and Nanog downregulation via p53 and enhances erythroid differentiation.

Authors:  Hee-Don Chae; Man-Ryul Lee; Hal E Broxmeyer
Journal:  Stem Cells       Date:  2012-02       Impact factor: 6.277

3.  Mapping the protein interaction network of the human COP9 signalosome complex using a label-free QTAX strategy.

Authors:  Lei Fang; Robyn M Kaake; Vishal R Patel; Yingying Yang; Pierre Baldi; Lan Huang
Journal:  Mol Cell Proteomics       Date:  2012-04-03       Impact factor: 5.911

Review 4.  Cycling or not cycling: cell cycle regulatory molecules and adult neurogenesis.

Authors:  Pierre Beukelaers; Renaud Vandenbosch; Nicolas Caron; Laurent Nguyen; Gustave Moonen; Brigitte Malgrange
Journal:  Cell Mol Life Sci       Date:  2011-11-09       Impact factor: 9.261

5.  Discovery of drug mode of action and drug repositioning from transcriptional responses.

Authors:  Francesco Iorio; Roberta Bosotti; Emanuela Scacheri; Vincenzo Belcastro; Pratibha Mithbaokar; Rosa Ferriero; Loredana Murino; Roberto Tagliaferri; Nicola Brunetti-Pierri; Antonella Isacchi; Diego di Bernardo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

Review 6.  CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation.

Authors:  A-S Tigan; F Bellutti; K Kollmann; G Tebb; V Sexl
Journal:  Oncogene       Date:  2015-10-26       Impact factor: 9.867

7.  Proteomic and Metabolomic Characterization of a Mammalian Cellular Transition from Quiescence to Proliferation.

Authors:  Ho-Joon Lee; Mark P Jedrychowski; Arunachalam Vinayagam; Ning Wu; Ng Shyh-Chang; Yanhui Hu; Chua Min-Wen; Jodene K Moore; John M Asara; Costas A Lyssiotis; Norbert Perrimon; Steven P Gygi; Lewis C Cantley; Marc W Kirschner
Journal:  Cell Rep       Date:  2017-07-18       Impact factor: 9.423

8.  Phosphorylation by cyclin C/cyclin-dependent kinase 2 following mitogenic stimulation of murine fibroblasts inhibits transcriptional activity of LSF during G1 progression.

Authors:  Utsav H Saxena; Christina M H Powell; Jill K Fecko; Roxanne Cacioppo; Hubert S Chou; Geoffrey M Cooper; Ulla Hansen
Journal:  Mol Cell Biol       Date:  2009-02-23       Impact factor: 4.272

9.  The structure of CDK4/cyclin D3 has implications for models of CDK activation.

Authors:  T Takaki; A Echalier; N R Brown; T Hunt; J A Endicott; M E M Noble
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

Review 10.  Cell cycle, CDKs and cancer: a changing paradigm.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.